Ge Wu
Five Prime Therapeutics
1650 Owens St.
Suite 200
San Francisco
USA
Name/email consistency: high
- HTS technologies in biopharmaceutical discovery. Wu, G., Doberstein, S.K. Drug Discov. Today (2006)
- Determining appropriate substrate conversion for enzymatic assays in high-throughput screening. Wu, G., Yuan, Y., Hodge, C.N. J. Biomol. Screen (2003)